Gene · 2224
Papers2,695
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,695
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Temperature impacts Atlantic salmon's (Salmo salar) immunological response to infectious salmon anemia virus (ISAv). | Fish Shellfish Immunol Rep | 2023 | 37293549 | PubTator, text mining | PubMed |
| Tight basis cycle representatives for persistent homology of large biological data sets. | PLoS Comput Biol | 2023 | 37253074 | PubTator, text mining | PubMed |
| Bisphosphonate-treatment of secondary chronic osteomyelitis of the jaw - a case report. | J Surg Case Rep | 2023 | 37251250 | PubTator, text mining | PubMed |
| Case Report: A Novel MVK Missense Mutation in the Sporadic Porokeratosis Ptychotropica in China. | Clin Cosmet Investig Dermatol | 2023 | 37250911 | PubTator, text mining | PubMed |
| Melatonin Confers NaCl Tolerance in Withaniacoagulans L. by Maintaining Na+/K+ Homeostasis, Strengthening the Antioxidant Defense System and Modulating Withanolides Synthesis-Related Genes. | Russ J Plant Physiol | 2023 | 37250622 | PubTator, text mining | PubMed |
| Crosstalk between cholesterol metabolism and psoriatic inflammation. | Front Immunol | 2023 | 37234169 | PubTator, text mining | PubMed |
| Synthesis of medium and large phostams, phostones, and phostines. | Beilstein J Org Chem | 2023 | 37229219 | PubTator, text mining | PubMed |
| Effects of antiresorptive agents on body composition: a case-control retrospective study. | Reumatologia | 2023 | 37223368 | PubTator, text mining | PubMed |
| An overview of the management of osteoporosis in the aging female population. | Womens Health (Lond) | 2023 | 37218715 | PubTator, text mining | PubMed |
| New insights into lipid metabolism and prostate cancer (Review). | Int J Oncol | 2023 | 37203395 | PubTator, text mining | PubMed |
| Development of the nonreceptor tyrosine kinase FER-targeting PROTACs as a potential strategy for antagonizing ovarian cancer cell motility and invasiveness. | J Biol Chem | 2023 | 37196766 | PubTator, text mining | PubMed |
| Discovery of Novel Bruton's Tyrosine Kinase PROTACs with Enhanced Selectivity and Cellular Efficacy. | J Med Chem | 2023 | 37195170 | PubTator, text mining | PubMed |
| Single-Cell Transcriptome Analysis Revealed Heterogeneity and Identified Novel Therapeutic Targets for Breast Cancer Subtypes. | Cells | 2023 | 37190091 | PubTator, text mining | PubMed |
| Mechanistic advances in osteoporosis and anti-osteoporosis therapies. | MedComm (2020) | 2023 | 37188325 | PubTator, text mining | PubMed |
| Immunohistochemical, pharmacovigilance, and omics analyses reveal the involvement of ATP-sensitive K+ channel subunits in cancers: role in drug-disease interactions. | Front Pharmacol | 2023 | 37180726 | PubTator, text mining | PubMed |
| Identifying therapeutic biomarkers of zoledronic acid by metabolomics. | Front Pharmacol | 2023 | 37180703 | PubTator, text mining | PubMed |
| Impaired Cholesterol Metabolism, Neurons, and Neuropsychiatric Disorders. | Exp Neurobiol | 2023 | 37164646 | PubTator, text mining | PubMed |
| Sexual dimorphism in obesity is governed by RELMα regulation of adipose macrophages and eosinophils. | Elife | 2023 | 37162190 | PubTator, text mining | PubMed |
| Proteogenomic characterization of ferroptosis regulators reveals therapeutic potential in glioblastoma. | BMC Cancer | 2023 | 37158834 | PubTator, text mining | PubMed |
| In vitro and in vivo effects of zoledronic acid on senescence and senescence-associated secretory phenotype markers. | Aging (Albany NY) | 2023 | 37154858 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2224/papers?page=13